Similar to the case of PARP and BRCA, Riabinska et. al. observed that cancers with ATM-deficiency are defective in HR and dependent on nonhomologous end joining (NHEJ) for DNA repair and cell survival [45]. This evidence concerns the gene ATM and cancer.